KAIROS PHARMA, LTD. (KAPA)
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies
LCI Industries Announces Leadership Transitions
Rights Offering and Identifying Details for New Securities-MYDAS R6
Zoetis - Zoetis Shares Resources and Tips for New World Screwworm Response and Management
Nu Holdings Announces US$1.0 Billion Share Repurchase Program
Ming Shing Group Holdings Limited Announces Resignation of Director and Re-designation of Chief Executive Officer
SciSparc SPRC Notification
SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum
Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society